CELL-SELEX: Novel perspectives of aptamer-based therapeutics. - Wikidata - wikimedia - TriplyDB

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

http://www.wikidata.org/entity/Q37424823

about

Targeting Th17 Cells with Small Molecules and Small Interference RNA In Vitro Selection of Cancer Cell-Specific Molecular Recognition Elements from Amino Acid Libraries Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy Manipulating the in vivo immune response by targeted gene knockdown Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting Deploying aptameric sensing technology for rapid pandemic monitoring.Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma.Targeted nanoagents for the detection of cancers Aptamers and the next generation of diagnostic reagents.Aptamer-targeted cell-specific RNA interference Strategies for the discovery of therapeutic aptamers.Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy Identification of an antibody fragment specific for androgen-dependent prostate cancer cells.Cell-type-specific aptamer and aptamer-small interfering RNA conjugates for targeted human immunodeficiency virus type 1 therapy.Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis.Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection antaRNA--Multi-objective inverse folding of pseudoknot RNA using ant-colony optimization.Selection of DNA aptamers for capture and detection of Salmonella Typhimurium using a whole-cell SELEX approach in conjunction with cell sorting.Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.Development of an efficient targeted cell-SELEX procedure for DNA aptamer reagents.Selection of LNA-containing DNA aptamers against recombinant human CD73.Aptamer-functionalized nano-biosensors.Development of RNA aptamers as molecular probes for HER2(+) breast cancer study using cell-SELEX.SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.Screening of aptamers on microfluidic systems for clinical applications Aptamer Selection Technology and Recent Advances.Ets1 identified as a novel molecular target of RNA aptamer selected against metastatic cells for targeted delivery of nano-formulation.Intraoperative stem cell therapy Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1.Targeted polymeric therapeutic nanoparticles: design, development and clinical translation Catch-and-Release of Target Cells Using Aptamer-Conjugated Electroactive Zwitterionic Oligopeptide SAM.Aptamer applications for targeted cancer therapy.Recent advances in ligand targeted therapy.Nucleic acid and peptide aptamers: fundamentals and bioanalytical aspects.Aptamer-conjugated gold nanoparticles for bioanalysis.Current progress on aptamer-targeted oligonucleotide therapeutics.Aptamers as targeted therapeutics: current potential and challenges.Identification and application of ssDNA aptamers against H₃₇Rv in the detection of Mycobacterium tuberculosis.Cell-specific aptamers as emerging therapeutics.

P2860

Q26770523-0FA22616-B707-430F-8588-679AA1D320FF Q26782129-7119AD74-F9C2-45DD-9BBF-B2B013452A96 Q26799218-E816A58A-A0E8-43A4-96CE-3A17927A2DAF Q28080168-1523B439-A0E1-48FC-A27D-0B6CDD09B2A0 Q28083494-69D30025-C9C0-4558-933D-0D96E4064843 Q28475666-97F3D913-06C7-4BC2-9735-C891507BB58E Q30252091-3F3CEC17-B704-40FC-92DB-D721F73A48F5 Q30434521-B6F70B2C-6CC2-416A-9BCB-807B7CB15017 Q30472641-AA3A27BD-6716-475E-A017-739965986455 Q33615065-F487A678-0192-42F3-B373-0E72647C2CA4 Q33717239-EF1D51CF-A26D-4D90-82DE-2B05EAEA2F29 Q33831862-3A511DF7-4FA2-4F64-B5CA-6AA2041056A8 Q33834772-AFC6808F-FDE2-4A6A-A459-F6DBC565C2C6 Q34152258-722024B7-F8FC-4271-98EA-194F88260500 Q34232003-1ABA9E6E-581F-41E3-B7FB-DB372AE485AE Q34240731-315C53CC-6B99-44CF-BEB1-C1CB006F7D72 Q34409758-0F8C5F4D-E860-428F-BB71-7E2E881014D3 Q34502120-42070D10-8B16-4853-96D1-A647CC39DDB6 Q34620935-304F3E25-62A6-4DF4-B4ED-A867A7562323 Q34695253-342D1836-5572-4F12-B56B-FCA8DFA98689 Q34964507-EA116BC8-B2F7-491E-A933-1262892C6828 Q35568409-4B474ED1-F7C6-4DDE-A732-98DA220B2A9B Q35701619-04638B14-B49A-4D30-9E1C-DBB927665868 Q35875889-4775050C-06CE-462D-B702-CF597E04568F Q35958678-775159C4-7E78-4244-8C2F-1E7F0686FE25 Q36239152-48FFD187-8984-475C-94ED-653454C7AF0B Q36256736-846FCF84-03D3-42B2-B0BE-90C9A8A7BA95 Q36394059-026E0AEA-697A-4ADD-9720-F7A2BDED0B22 Q36822337-A3772F1A-A6FB-47D3-BB72-D1D71E813739 Q36839458-1629CF1E-9137-4E74-92E7-394601C0F9FB Q36934007-7ED546A9-D83A-4E45-9428-31CEBDB26368 Q37684085-4CA6278D-6DEC-4558-BE1B-50B769F33016 Q37771956-812BE550-F481-4A95-AEDD-0C306B614D74 Q37937611-A5418651-E76F-4583-B818-11F13526C10F Q37972851-DE28C782-DC06-4503-8187-72C1BB12237F Q38111403-1E4BA60C-41FB-4115-A3AC-1ECFF588FB48 Q38168595-0C9A495A-8106-4A40-9FC9-E13AE73FBD68 Q38290290-73661969-7982-4D87-83BE-21646738F848 Q38297501-27FABF34-AC53-4CBD-BB1E-61380E4E785B Q38302347-CD660991-554A-45A3-9E0E-C6D90C2AB7F4

P2860

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

http://www.wikidata.org/entity/Q37424823

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 April 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@en

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@nl

type

label

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@en

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@nl

prefLabel

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@en

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@nl

P1433

Q37424823-0954D97E-BEC7-4779-B24F-B7F3E9455494

P1476

Q37424823-3E0282E3-C95B-499C-AB79-0D3C4FA7C239

P2093

Q37424823-119E04CA-8B78-4A25-89B7-FAF381B5D9D5

Q37424823-BDACEE7E-3DB2-4350-9358-D2BA47609152

Q37424823-DCD2AEE2-D0F8-4102-9A38-53B32BDCC580

Q37424823-F3B414B6-6015-44B4-AB6C-966A504632CE

P2860

Q37424823-038B7F53-03A9-4A27-A052-83F39847CD33

Q37424823-07B0EE24-CA87-44D4-A219-9D3DB6072770

Q37424823-08D68B9C-3D7A-4237-9646-A60F6B02537D

Q37424823-0A406446-C6A6-4048-81B8-8376EC935707

Q37424823-0C6961A3-CB5D-4F28-9E29-CE849CB93023

Q37424823-1259925E-C0BC-4A0B-B6C4-0AA1548C67A3

Q37424823-12B673AB-AFB8-4E0F-B52E-E4944E47BFB0

Q37424823-1322DBF8-6D13-4128-B153-3CB32929FA58

Q37424823-1B030CBB-CD18-4931-9BBA-36174CBEE285

Q37424823-1E564BAE-7388-4C0C-A25C-9F56A8A7CC67

P304

Q37424823-48302353-6C69-4859-84C2-D866EC91BB28

P31

Q37424823-59B5124D-8EDB-4F5F-B3A6-0ADAE7B936BD

P356

Q37424823-F1DBE7A9-5DE2-4C60-B4DE-7B87439425F5

P407

Q37424823-32C538EB-8BD1-478D-A01C-ED8C32540434

P433

Q37424823-2B3DAC0C-62C8-42AD-810A-5E67C4BB426C

P478

Q37424823-B4780282-F48D-4D2A-B978-77175D3BAB0E

P577

Q37424823-687F135F-B220-48F1-A17B-8906579DEFED

P5875

Q37424823-05E1A0FA-870F-44BE-8FE7-695844622449

P698

Q37424823-663BCC1A-0965-4DA2-B309-887ED83D8B35

P932

Q37424823-3D516A8A-A903-4A81-A9EA-7304E11A7993

P356

P1433

International Journal of Molecular Sciences

P1476

CELL-SELEX: Novel perspectives of aptamer-based therapeutics.

@en

P2093

Angela Paul

http://www.w3.org/2001/XMLSchema#string

Gerhard Ziemer

http://www.w3.org/2001/XMLSchema#string

Hans P Wendel

http://www.w3.org/2001/XMLSchema#string

Ke-Tai Guo

http://www.w3.org/2001/XMLSchema#string

P2860

A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase

Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase

In vitro selection of RNA molecules that bind specific ligands

Apoptosis in the pathogenesis and treatment of disease

Discovery and development of anticancer aptamers

Aptamers as reagents for high-throughput screening.

Aptamers: an emerging class of molecules that rival antibodies in diagnostics.

Sequence-specific peptide aptamers, interacting with the intracellular domain of the epidermal growth factor receptor, interfere with Stat3 activation and inhibit the growth of tumor cells.

SELEX experiments: new prospects, applications and data analysis in inferring regulatory pathways.

P304

668-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/IJMS9040668

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24238369

http://www.w3.org/2001/XMLSchema#string

P698

19325777

http://www.w3.org/2001/XMLSchema#string

P932

2635693

http://www.w3.org/2001/XMLSchema#string